Ranbaxy Malaysia Sdn Bhd, a wholly owned subsidiary of Ranbaxy Laboratories has received the approval from Government of Malaysia for setting up a Greenfield manufacturing facility in Malaysia as an EPP (Entry Point Project).
Ranbaxy will be investing around RM 125 Million ($40 Million) in this project that will provide employment to over 200 people. It will be Ranbaxy's second manufacturing facility in Malaysia.
Ranbaxy Laboratories, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies
